Ann: Positive results reaffirm plans to advance ATL1102 to P2b, page-54

@Akki re "long game" geeeeeez I hope that's not news to anyone here. And for anyone to whom it is news, here's some reading for you: https://www.medtran.ru/eng/trials/trial_phases.htm

Every step, every phase, every trial, comes with a risk of failure, and a hard financial cost. But guess what bruh? That's why ANP has a MC of less than $40m. Given its potential, as highlighted by today's announcement, is that juuuuust a little bit undercooked? Well obviously some people think so, given that as I type, nearly $1m in stock has traded today, and it's up 10% on last. Given the likelihood of people recycling cash and/or arbing the options, my own view is it's being held back some. We'll see.





[also, realised my disc has wrongly said not held - amended now.]